US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5849719A
(en)
*
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
JP4111403B2
(ja)
*
|
1996-10-11 |
2008-07-02 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
免疫刺激ポリヌクレオチド/免疫調節分子複合体
|
ATE331030T1
(de)
*
|
1996-11-04 |
2006-07-15 |
Ottawa Health Research Inst |
Verfahren zur expression von polypeptide in fishen durch wässerung in dns enthaltende lösung
|
AU738384B2
(en)
*
|
1996-11-04 |
2001-09-20 |
Qiagen Gmbh |
Cationic reagents for transfection
|
EP0855184A1
(fr)
*
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Composition pharmaceutique comprenant un polynucléotide et un antigène notamment pour la vaccination
|
WO1998040100A1
(fr)
*
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
UTILISATION D'ACIDES NUCLEIQUES CONTENANT UN DINUCLEOTIDE CpG NON METHYLE EN TANT QU'ADJUVANT
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
TR199902522T2
(xx)
*
|
1997-04-11 |
2000-04-21 |
B. Of S.Visors Of Louisiana State Uni. & Agricul.& |
Bal�k patojenlerine kar�� zay�flat�lm�� invazif a��.
|
US6010705A
(en)
*
|
1997-04-11 |
2000-01-04 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Attenuated, invasive vaccines against fish pathogens
|
US6339068B1
(en)
|
1997-05-20 |
2002-01-15 |
University Of Iowa Research Foundation |
Vectors and methods for immunization or therapeutic protocols
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6589940B1
(en)
*
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6348450B1
(en)
*
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
JP2002508386A
(ja)
|
1997-12-16 |
2002-03-19 |
ザ・ユニバーシティー・オブ・サスカチワン・テクノロジーズ・インコーポレーテッド |
導電性金属含有核酸
|
US6153202A
(en)
*
|
1998-03-06 |
2000-11-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
|
CA2323929C
(fr)
*
|
1998-04-03 |
2004-03-09 |
University Of Iowa Research Foundation |
Procedes et produits servant a stimuler le systeme immunitaire au moyen d'oligonucleotides et de cytokines immunotherapeutiques
|
WO1999056755A1
(fr)
*
|
1998-05-06 |
1999-11-11 |
University Of Iowa Research Foundation |
Methodes de prevention et de traitement des parasitoses et maladies associees a l'aide d'oligonucleotides cpg
|
CA2328406A1
(fr)
*
|
1998-05-14 |
1999-11-18 |
Hermann Wagner |
Procedes de regulation de l'hematopoiese au moyen d'oligonucleotides a cpg
|
NZ508927A
(en)
|
1998-05-22 |
2003-12-19 |
Ottawa Health Research Inst |
Methods and products for inducing mucosal immunity
|
US6881561B1
(en)
*
|
1998-05-27 |
2005-04-19 |
Cheil Jedang Corporation |
Endonuclease of immune cell, process for producing the same and immune adjuvant using the same
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6462027B2
(en)
|
1998-07-06 |
2002-10-08 |
University Of Georgia Research Foundation, Inc. |
Delivery of nucleic acid into aquatic animals
|
US20070071776A1
(en)
*
|
1998-09-28 |
2007-03-29 |
National University Of Singapore |
Recombinant Vaccine Against Fish Infectious Diseases
|
US7160869B2
(en)
*
|
1998-12-16 |
2007-01-09 |
University Of Saskatchewan |
Biologically active metal-containing nucleic acids
|
US7326568B2
(en)
*
|
1999-02-04 |
2008-02-05 |
University Of Georgia Research Foundation, Inc. |
Recombinant expression of heterologous nucleic acids in protozoa
|
US6846481B1
(en)
|
1999-02-04 |
2005-01-25 |
University Of Georgia Research Foundation, Inc. |
Recombinant expression of heterologous nucleic acids in protozoa
|
US7026156B1
(en)
|
1999-02-04 |
2006-04-11 |
The University Of Georgia Research Foundation, Inc. |
Diagnostic and protective antigen gene sequences of ichthyophthirius
|
EP1151118B1
(fr)
*
|
1999-02-04 |
2008-04-09 |
The University Of Georgia Research Foundation, Inc. |
Expression recombinante d'acides nucleiques heterologues dans un protozoaire
|
JP5084984B2
(ja)
|
1999-02-17 |
2012-11-28 |
シーエスエル、リミテッド |
免疫原複合体およびそれに関する方法
|
US7683035B1
(en)
|
1999-02-23 |
2010-03-23 |
Qiagen, Gmbh |
Method of stabilizing and/or isolating nucleic acids
|
EP1177440A1
(fr)
*
|
1999-04-15 |
2002-02-06 |
Genetics Institute, Inc. |
Proteines secretees et polynucleotides codant ces dernieres
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
NO311648B1
(no)
*
|
1999-05-31 |
2001-12-27 |
Genomar Asa |
DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
|
WO2000074650A2
(fr)
*
|
1999-06-04 |
2000-12-14 |
Alza Corporation |
Compositions de gel implantables et procede de fabrication
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
US20040109874A1
(en)
*
|
1999-11-10 |
2004-06-10 |
Powderject Vaccines, Inc. |
Induction of mucosal immunity by vaccination via the skin route
|
AU2001229677A1
(en)
*
|
2000-01-28 |
2001-08-07 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
AU2001251407A1
(en)
*
|
2000-04-07 |
2001-10-23 |
The Regents Of The University Of California |
Synergistic improvements to polynucleotide vaccines
|
US20030022359A1
(en)
|
2000-06-20 |
2003-01-30 |
Sayre Richard T. |
Transgenic algae for delivering antigens to an animal
|
JP2003535907A
(ja)
|
2000-06-22 |
2003-12-02 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
抗体誘導性細胞溶解を促進し、そして癌を処置するための方法
|
US7083858B1
(en)
|
2000-07-26 |
2006-08-01 |
Worthen Industries, Inc. |
Thermally activated adhesive films for the collation of wire staples
|
WO2002036618A1
(fr)
*
|
2000-11-04 |
2002-05-10 |
Rna Inc. |
Nouveaux genes codant pour les proteines g et m1 d'un virus coreen isole de la necrose hematopoietique infectieuse-scs (nhi-scs) et vaccin permettant de lutter contre le virus de la necrose hematopoietique infectieuse chez un salmonide
|
EP1350262B8
(fr)
|
2000-12-08 |
2008-08-13 |
Coley Pharmaceuticals GmbH |
Acides nucleiques du type cpg et procedes d'utilisation correspondants
|
US7906492B2
(en)
*
|
2001-01-16 |
2011-03-15 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
EP1390075B1
(fr)
*
|
2001-04-06 |
2012-01-18 |
The University of Chicago |
Induction chimiotherapeutique de l'activite du promoteur egr-1 dans la therapie genique
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
JP4338402B2
(ja)
|
2001-05-22 |
2009-10-07 |
ユニバーシティ オブ シカゴ |
N4ウイルス一本鎖dna依存的rnaポリメラーゼ
|
EP1389350A1
(fr)
*
|
2001-05-24 |
2004-02-18 |
University of Saskatchewan Technologies Inc. |
Procedes et elements pour circuit a acides nucleiques
|
WO2003013597A1
(fr)
*
|
2001-08-10 |
2003-02-20 |
University Of Maryland Biotechnology Institute |
Vaccin sous-unite pour le virus de necrose pancreatique infectieux
|
IL160157A0
(en)
|
2001-08-17 |
2004-07-25 |
Coley Pharm Group Inc |
Combination motif immune stimulation oligonucleotides with improved activity
|
JP4863341B2
(ja)
*
|
2001-09-06 |
2012-01-25 |
Meiji Seikaファルマ株式会社 |
ヒラメラブドウイルス感染魚類用dnaワクチン
|
US20030091593A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
EP1450856B1
(fr)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Emballage de cpg dans des particules de type virus : procede de preparation et utilisation correspondante
|
AR037038A1
(es)
|
2001-10-26 |
2004-10-20 |
Baylor College Medicine |
Una composicion y metodo para alterar la masa corporal magra y las propiedades oseas en un sujeto
|
AU2002340662B2
(en)
*
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
CA2469310C
(fr)
|
2001-12-11 |
2013-01-29 |
Advisys, Inc. |
Supplementation administree par plasmides pour le traitement de patients a maladie chronique
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP2221377B2
(fr)
|
2002-02-01 |
2017-05-17 |
Life Technologies Corporation |
Oligonucletides double brin
|
WO2003064621A2
(fr)
|
2002-02-01 |
2003-08-07 |
Ambion, Inc. |
Courts fragments d'arn interferant haute activite visant a reduire l'expression de genes cibles
|
US20030158103A1
(en)
*
|
2002-02-19 |
2003-08-21 |
Aqua Bounty Farms, Inc. |
Prevention of viral and bacterial disease in shrimp
|
US20040147467A1
(en)
*
|
2002-03-29 |
2004-07-29 |
Clouthier Sharon C. |
Nucleic acids encoding isav polypeptides
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
KR100456681B1
(ko)
*
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
*
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US6916474B2
(en)
|
2002-07-15 |
2005-07-12 |
Board Of Regents, The University Of Texas System |
Antibodies with increased affinities for anthrax antigens
|
EP2044948B1
(fr)
|
2002-08-12 |
2013-10-30 |
Jennerex Biotherapeutics ULC |
Virus de vaccinia pour utilisation dans une méthode de traitement du cancer
|
US7501128B2
(en)
*
|
2002-09-17 |
2009-03-10 |
Novartis Animal Health Us, Inc. |
IHNV G protein for immune stimulation
|
BR0315810A
(pt)
|
2002-10-29 |
2005-09-13 |
Coley Pharmaceutical Group Ltd |
Uso de oligonucleotìdeos cpg no tratamento de infecção por vìrus da hepatite c
|
EP1578954A4
(fr)
|
2002-12-11 |
2010-08-11 |
Coley Pharm Group Inc |
Acides nucleiques 5'cpg et leurs methodes d'utilisation
|
TW201139672A
(en)
|
2002-12-13 |
2011-11-16 |
Novartis Ag |
Immunization of fish with plant-expressed recombinant proteins
|
IL153775A0
(en)
*
|
2003-01-01 |
2003-07-31 |
Yissum Res Dev Co |
Immunizing fish against viral infection
|
WO2004084940A1
(fr)
*
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Encapsulation d'oligonucleotides immunostimulateurs dans des particules pseudovirales, procedes de preparation et utilisations
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
US7790189B2
(en)
|
2003-05-15 |
2010-09-07 |
Mitsui Sugar Co., Ltd. |
Immunostimulating agents
|
US20070224615A1
(en)
*
|
2003-07-09 |
2007-09-27 |
Invitrogen Corporation |
Methods for assaying protein-protein interactions
|
CN1894581B
(zh)
|
2003-07-09 |
2012-02-01 |
生命技术公司 |
检测蛋白-蛋白相互作用的方法
|
GB0317733D0
(en)
|
2003-07-29 |
2003-09-03 |
Novartis Ag |
Organic compounds
|
AU2004275876B2
(en)
*
|
2003-09-25 |
2011-03-31 |
Coley Pharmaceutical Gmbh |
Nucleic acid-lipophilic conjugates
|
US7204993B2
(en)
*
|
2004-03-18 |
2007-04-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Streptococcus agalactiae vaccine
|
EP1735435A1
(fr)
*
|
2004-03-18 |
2006-12-27 |
Fred Hutchinson Cancer Research Center |
Procedes et compositions impliquant des regions de promoteur s-ship
|
TWI235440B
(en)
*
|
2004-03-31 |
2005-07-01 |
Advanced Semiconductor Eng |
Method for making leadless semiconductor package
|
US20080286294A1
(en)
*
|
2004-05-19 |
2008-11-20 |
Agence Francaise De Securite Sanitaire Des Aliment |
Nodavirus-Vlp Immunization Composition
|
WO2006017279A2
(fr)
*
|
2004-07-12 |
2006-02-16 |
Board Of Regents, The University Of Texas System |
Procédés et compositions concernant l'identification des interactions protéine-protéine
|
KR100958505B1
(ko)
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
US7334538B1
(en)
*
|
2004-07-27 |
2008-02-26 |
Aquascience Research Group, Inc. |
Topical medicants for aquatic animals
|
ES2247942B1
(es)
*
|
2004-08-27 |
2006-10-01 |
Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) |
Construccion genica, vector y vacuna adn para la vacunacion de animales acuaticos.
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
KR100701672B1
(ko)
*
|
2004-12-10 |
2007-04-03 |
대한민국 |
한국형 돌돔 이리도바이러스의 유전자 및 이를 이용한 백신
|
AU2006216671A1
(en)
*
|
2005-02-23 |
2006-08-31 |
The Uab Research Foundation |
Alkyl-glycoside enhanced vaccination
|
EP1904530A2
(fr)
*
|
2005-07-07 |
2008-04-02 |
Coley Pharmaceutical Group, Inc. |
Polytherapie associant un anticorps anti-ctla-4 et un oligodesoxynucleotide synthetique a motif cpg destinee au traitement du cancer
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
CA2621982C
(fr)
*
|
2005-09-07 |
2017-11-28 |
Jennerex Biotherapeutics Ulc |
Traitement systemique de cancers metastasiques et/ou systemiquement dissemines a l'aide de poxvirus exprimant le gm-csf
|
CN100370023C
(zh)
*
|
2005-11-17 |
2008-02-20 |
中国海洋大学 |
利用大菱鲆鳍细胞系繁殖大菱鲆出血性败血症病毒的方法
|
WO2007080203A1
(fr)
*
|
2006-01-11 |
2007-07-19 |
Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (Inia) |
Construction genique, vecteur et vaccin d'adn pour la vaccination d'animaux aquatiques
|
US20090053221A1
(en)
*
|
2006-01-17 |
2009-02-26 |
Cheung Nai-Kong V |
Immune response enhancing glucan
|
US8323644B2
(en)
|
2006-01-17 |
2012-12-04 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
EP2368570A3
(fr)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions et procédés liés aux protéines des bactéries staphylocoques
|
CN101495636B
(zh)
|
2006-04-13 |
2012-12-05 |
国立大学法人东京海洋大学 |
锦鲤疱疹病毒(khv)病用dna疫苗
|
WO2008014484A1
(fr)
|
2006-07-27 |
2008-01-31 |
University Of Maryland, Baltimore |
Récepteur cellulaire du facteur antiprolifération
|
CN102026645B
(zh)
*
|
2006-09-15 |
2016-01-27 |
渥太华医院研究机构 |
溶瘤弹状病毒
|
BRPI0717474A2
(pt)
*
|
2006-10-20 |
2014-03-11 |
Arizona Board Of Regentes For And On Behalf Of Arizona State University |
Cianobactéria modificada
|
CA2671264C
(fr)
|
2006-11-30 |
2015-11-24 |
Research Development Foundation |
Bibliotheques d'immunoglobulines ameliorees
|
NZ578541A
(en)
*
|
2006-12-22 |
2012-04-27 |
Soluciones Biotecnologicas Innovacion Ltda |
Dna vaccines for fish
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
EP2155789B1
(fr)
|
2007-05-01 |
2013-07-24 |
Research Development Foundation |
Banques d'immunoglobulines fc
|
US20100317084A1
(en)
*
|
2007-05-10 |
2010-12-16 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens
|
EP2150616A4
(fr)
|
2007-05-10 |
2011-07-27 |
Univ Arizona |
Expression régulée d'antigène et/ou atténuation régulée pour accroître l'immunogénicité et/ou la sécurité de vaccins
|
CA2697538C
(fr)
|
2007-08-31 |
2019-02-12 |
University Of Chicago |
Procedes et compositions associees pour immuniser contre des maladies et des etats staphylococciques des poumons
|
GB0717911D0
(en)
|
2007-09-14 |
2007-10-24 |
Univ Stirling |
Vaccine
|
US8465755B2
(en)
*
|
2007-10-05 |
2013-06-18 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting an immune response against enteric pathogens
|
JP5677703B2
(ja)
|
2008-01-10 |
2015-02-25 |
リサーチ ディベロップメント ファウンデーション |
Ehrlichiachaffeensisにのためのワクチンおよび診断
|
PL2245464T3
(pl)
|
2008-01-25 |
2017-08-31 |
Multivir Inc. |
Biomarkery p53
|
RU2010139426A
(ru)
|
2008-03-17 |
2012-04-27 |
Зе Скрипс Ресеч Инститьют (Us) |
Комбинация химического и генетического подходов к получению индуцированных плюрипотентных стволовых клеток
|
GB0808780D0
(en)
*
|
2008-05-15 |
2008-06-18 |
Big Dna Ltd |
Fish vaccines
|
KR101648019B1
(ko)
|
2008-06-04 |
2016-08-16 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
비-바이러스 접근법을 사용한 iPS 세포의 생산 방법
|
US9175268B2
(en)
|
2008-08-12 |
2015-11-03 |
Cellular Dynamics International, Inc. |
Methods for the production of iPS cells
|
US8912146B2
(en)
|
2008-08-18 |
2014-12-16 |
University Of Maryland, Baltimore |
Derivatives of APF and methods of use
|
JP2012504660A
(ja)
|
2008-10-06 |
2012-02-23 |
ユニバーシティ オブ シカゴ |
細菌eap、empおよび/またはadsaタンパク質に関連する組成物および方法
|
WO2010045620A1
(fr)
|
2008-10-17 |
2010-04-22 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Bactérie recombinante pouvant éliciter une réponse immunitaire contre le streptococcus pneumoniae
|
JP5651125B2
(ja)
|
2008-12-10 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Mek阻害剤に対する耐性を付与するmek突然変異
|
EP3312269A1
(fr)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Génération et entretien de cellules souches
|
EP2379720B1
(fr)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Thérapie anticancéreuse ciblée entraînée par le promoteur de mir-21
|
US20100183523A1
(en)
|
2009-01-22 |
2010-07-22 |
Wagner Richard E |
Dental composition and method
|
KR20170102039A
(ko)
|
2009-04-03 |
2017-09-06 |
유니버시티 오브 시카고 |
단백질 A(SpA) 변이체와 관련된 조성물 및 방법
|
US9163219B2
(en)
*
|
2009-04-14 |
2015-10-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Single expression vector for generation of a virus with a segmented genome
|
EP2424885B1
(fr)
|
2009-04-28 |
2016-03-23 |
Vanderbilt University |
Compositions et procédés pour le traitement de troubles mettant en jeu une apoptose de cellules épithéliales
|
GB2483595B
(en)
|
2009-05-22 |
2017-03-29 |
The Arizona Board Of Regents For And On Behalf Of Arizona State Univ |
Recombinant bacterium and methods of antigen and nucleic acid delivery
|
US9045742B2
(en)
*
|
2009-05-29 |
2015-06-02 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant Edwardsiella bacterium
|
AU2010254811B2
(en)
|
2009-06-05 |
2015-02-19 |
FUJIFILM Cellular Dynamics, Inc. |
Reprogramming T cells and hematopoietic cells
|
US20110053803A1
(en)
|
2009-08-26 |
2011-03-03 |
Xin Ge |
Methods for creating antibody libraries
|
ES2848650T3
(es)
|
2009-09-14 |
2021-08-11 |
Sillajen Biotherapeutics Inc |
Terapia combinada contra el cáncer con virus vaccinia oncolítico
|
WO2011045573A2
(fr)
|
2009-10-15 |
2011-04-21 |
University Court Of The University Of Edinburgh |
Antigènes staphylococciques
|
JP5808331B2
(ja)
|
2009-10-16 |
2015-11-10 |
ザ スクリプス リサーチ インスティテュート |
多能性細胞の誘導法
|
CN102858959B
(zh)
|
2009-12-10 |
2016-02-24 |
渥太华医院研究院 |
溶瘤弹状病毒
|
US9062297B2
(en)
|
2010-01-13 |
2015-06-23 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Yersinia pestis vaccine
|
WO2011091291A1
(fr)
|
2010-01-22 |
2011-07-28 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Bactérie renfermant un acide nucléique régulé par le rfah
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
ES2674682T3
(es)
|
2010-02-25 |
2018-07-03 |
Dana-Farber Cancer Institute, Inc. |
Mutaciones de BRAF que confieren resistencia a inhibidores de BRAF
|
WO2011108930A1
(fr)
|
2010-03-04 |
2011-09-09 |
Interna Technologies Bv |
Molécule de miarn définie par sa source et ses utilisations thérapeutiques et en diagnostic pour maladies ou états associés à l'emt
|
CN102959076B
(zh)
|
2010-03-31 |
2015-09-16 |
斯克里普斯研究所 |
重编程细胞
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
WO2011126976A1
(fr)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Vaccins à réovirus et procédés d'utilisation associés
|
DK2560672T3
(en)
|
2010-04-19 |
2014-03-17 |
Res Dev Foundation |
RTEF-1 variants and their uses
|
WO2011150421A2
(fr)
|
2010-05-28 |
2011-12-01 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Bactérie recombinante permettant de diminuer la croissance tumorale
|
ES2873933T3
(es)
|
2010-06-09 |
2021-11-04 |
Dana Farber Cancer Inst Inc |
Una mutación de MEK1 que confiere resistencia a inhibidores de RAF y de MEK
|
ES2685171T3
(es)
|
2010-06-14 |
2018-10-05 |
The Scripps Research Institute |
Reprogramación de células a un nuevo destino
|
CA2802087A1
(fr)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Compendium de modeles de cellules souches prefabriques pour l'interrogation d'une reponse biologique
|
EP2582794B2
(fr)
|
2010-06-15 |
2024-04-24 |
FUJIFILM Cellular Dynamics, Inc. |
Génération de cellules souches pluripotentes induites à partir de petits volumes de sang périphérique
|
KR20130093084A
(ko)
|
2010-07-02 |
2013-08-21 |
더 유니버시티 오브 시카고 |
단백질 A(SpA) 변이체와 관련된 조성물 및 방법
|
NZ719520A
(en)
|
2010-07-06 |
2017-07-28 |
Int Tech Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
CA2804595C
(fr)
|
2010-07-07 |
2018-11-13 |
Cellular Dynamics International, Inc. |
Production de cellules endotheliales par programmation
|
CA2806858C
(fr)
|
2010-08-04 |
2021-06-15 |
Cellular Dynamics International, Inc. |
Reprogrammation des lymphocytes b immortalises
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
FR2964569B1
(fr)
|
2010-09-10 |
2012-10-19 |
Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad |
Nouveaux liposomes de vaccination genique
|
EP3536337A1
(fr)
|
2010-09-22 |
2019-09-11 |
The Regents of the University of Colorado, a body corporate |
Applications thérapeutiques de smad7
|
EP2622065B1
(fr)
|
2010-10-01 |
2016-09-07 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Manipulation de la fonction de cellules souches par des isoformes p53
|
US9732319B2
(en)
|
2010-12-22 |
2017-08-15 |
Fate Therapeutics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
JP6121910B2
(ja)
|
2011-01-04 |
2017-04-26 |
シラジェン バイオセラピューティクス インコーポレイテッド |
腫瘍溶解性ワクシニアウイルスの投与による腫瘍抗原に対する抗体の生成および腫瘍特異的補体依存性細胞傷害の生成
|
EP2474617A1
(fr)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR pour traiter une nouvelle angiogenèse
|
US8952132B2
(en)
|
2011-02-07 |
2015-02-10 |
Research Development Foundation |
Engineered immunoglobulin FC polypeptides
|
WO2012109208A2
(fr)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Production de précurseurs hématopoïétiques obtenus par programmation
|
EP3406628A1
(fr)
|
2011-04-08 |
2018-11-28 |
Evaxion Biotech ApS |
Protéines et acides nucléiques utiles dans des vaccins ciblant le staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012156535A1
(fr)
|
2011-05-19 |
2012-11-22 |
Fundación Progreso Y Salud |
Système tet-on lentiviral à double promoteur très inductible
|
ES2627529T3
(es)
|
2011-06-08 |
2017-07-28 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Composiciones para tratamiento de glioblastoma
|
WO2013009825A1
(fr)
|
2011-07-11 |
2013-01-17 |
Cellular Dynamics International, Inc. |
Procédés de reprogrammation cellulaire et d'ingénierie génomique
|
CN103906535B
(zh)
|
2011-08-15 |
2017-07-14 |
芝加哥大学 |
与葡萄球菌蛋白a的抗体相关的组合物和方法
|
US20130101664A1
(en)
|
2011-08-18 |
2013-04-25 |
Donald W. Kufe |
Muc1 ligand traps for use in treating cancers
|
US9345760B2
(en)
|
2011-09-09 |
2016-05-24 |
Advanced Bionutrition Corporation |
IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
|
US9273102B2
(en)
|
2011-10-12 |
2016-03-01 |
Niels Iversen Møller |
Peptides derived from Campylobacter jejuni and their use in vaccination
|
DK2788110T3
(en)
|
2011-12-08 |
2019-02-11 |
Pentair Water Pool & Spa Inc |
AQUACULTURE SYSTEM AND PROCEDURE TO OPERATE A PUMP IN SUCH A SYSTEM
|
US10174314B2
(en)
|
2011-12-22 |
2019-01-08 |
Interna Technologies B.V. |
MiRNA for treating head and neck cancer
|
WO2013144579A1
(fr)
|
2012-03-30 |
2013-10-03 |
Heriot-Watt University |
Utilisation de flagelline en tant que vaccin
|
CA2910320A1
(fr)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions et procedes associes a des anticorps qui neutralisent l'activite coagulase dans une maladie a staphylococcus aureus
|
EP3805395A1
(fr)
|
2012-04-26 |
2021-04-14 |
University Of Chicago |
Antigènes des staphylocoques coagulase et leurs méthodes d'utilisation
|
US9303264B2
(en)
|
2012-05-18 |
2016-04-05 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Photosynthetic microorganisms expressing thermostable lipase
|
EP2870238A4
(fr)
|
2012-07-05 |
2016-03-09 |
Ohio State Innovation Foundation |
Compositions et procédés associés à des vaccins viraux
|
CN104736169B
(zh)
*
|
2012-09-10 |
2018-04-17 |
国立大学法人东京海洋大学 |
海产鱼的类结节病用dna疫苗
|
WO2014046410A1
(fr)
*
|
2012-09-20 |
2014-03-27 |
중앙대학교 산학협력단 |
Procédé de production de particules de type virus de nodavirus, lignée de cellules de levure exprimant celui-ci, et composition de vaccin contenant celui-ci
|
WO2014065945A1
(fr)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Anticorps avec des domaines fc d'igg modifiés
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
WO2014116721A1
(fr)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Vecteur geminiviral pour l'expression du rituximab
|
EP2958990B1
(fr)
|
2013-02-20 |
2019-10-16 |
Regeneron Pharmaceuticals, Inc. |
Modification génétique de rats
|
US10363293B2
(en)
|
2013-02-21 |
2019-07-30 |
Turnstone Limited Partnership |
Vaccine composition
|
WO2014130770A1
(fr)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Production d'hépatocytes par programmation aller par génie génétique et chimique combiné
|
EP2961386B1
(fr)
|
2013-02-28 |
2019-07-10 |
The General Hospital Corporation |
Compositions de profilage de miarn et procédés d'utilisation
|
US20160010094A1
(en)
|
2013-03-01 |
2016-01-14 |
University Of Pretoria |
Transgenic cell selection
|
CN105358704B
(zh)
|
2013-03-08 |
2020-01-03 |
科罗拉多大学董事会 |
Ptd-smad7治疗剂
|
EP2969158A4
(fr)
|
2013-03-14 |
2016-12-21 |
Pentair Water Pool & Spa Inc |
Système de régulation de dioxyde de carbone destiné à l'aquaculture
|
WO2014145661A1
(fr)
|
2013-03-15 |
2014-09-18 |
Pentair Water Pool And Spa, Inc. |
Système de régulation d'oxygène dissous pour une aquaculture
|
US9580718B2
(en)
|
2013-06-17 |
2017-02-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Attenuated live bacteria with increased acid resistance and methods of use thereof
|
AU2014292926B2
(en)
|
2013-07-25 |
2020-03-05 |
Exicure Operating Company |
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
|
CA2923857A1
(fr)
|
2013-09-09 |
2015-03-12 |
Figene, Llc |
Therapie genique pour la regeneration de cellules de type chondrocytes ou cartilagineuses
|
CA2929555A1
(fr)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
La localisation nucleaire de glp-1 stimule la regeneration myocardique et entraine la regression d'une insuffisance cardiaque
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
MX369329B
(es)
*
|
2013-11-15 |
2019-11-05 |
Univ Maryland |
Metodo para la produccion de peces infertiles y animales acuaticos productores de huevos y para la administracion de compuestos en huevos y embriones.
|
EP4227685A3
(fr)
|
2013-12-03 |
2024-02-28 |
Evaxion Biotech A/S |
Proteines et acides nucleiques utiles dans des vaccins ciblant staphylococcus aureus
|
KR102448454B1
(ko)
|
2014-01-29 |
2022-09-28 |
다나-파버 캔서 인스티튜트 인크. |
Muc1-c/세포외 도메인 (muc1-c/ecd)에 대한 항체
|
US10214741B2
(en)
|
2014-02-14 |
2019-02-26 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
WO2015130783A1
(fr)
|
2014-02-25 |
2015-09-03 |
Research Development Foundation |
Peptides sty pour l'inhibition de l'angiogenèse
|
EP3805369A1
(fr)
|
2014-03-04 |
2021-04-14 |
Fate Therapeutics, Inc. |
Procédés améliorés de reprogrammation et plateformes de culture cellulaire
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
PL3164113T3
(pl)
|
2014-06-04 |
2019-09-30 |
Exicure, Inc. |
Wielowartościowe dostarczanie modulatorów immunologicznych w liposomowych kolistych kwasach nukleinowych do zastosowań profilaktycznych lub terapeutycznych
|
US20180363070A9
(en)
|
2014-08-12 |
2018-12-20 |
Univ Wayne State |
Systems and methods to detect stem cell stress and uses thereof
|
WO2016075305A2
(fr)
|
2014-11-13 |
2016-05-19 |
Evaxion Biotech Aps |
Peptides dérivés d'acinetobacter baumannii et leur utilisation en vaccination
|
CA2968531A1
(fr)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
Absorption cellulaire specifique a une sequence de conjugues nanoparticulaires d'acides nucleiques spheriques
|
EP4279080A3
(fr)
|
2015-01-12 |
2024-02-21 |
Evaxion Biotech A/S |
Traitement et prophylaxie d'une infection k. pneumoniae
|
WO2016120697A1
(fr)
|
2015-01-28 |
2016-08-04 |
Sabic Global Technologies B.V. |
Procédés et compositions pour une production à haut rendement de biocarburant et/ou de biomasse
|
WO2016130516A1
(fr)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Polypeptides ayant un domaine fc d'immunoglobuline modifié manifestant une activation du complément améliorée
|
US11421229B2
(en)
|
2015-02-20 |
2022-08-23 |
Baylor College Of Medicine |
p63 inactivation for the treatment of heart failure
|
WO2016196366A1
(fr)
|
2015-05-29 |
2016-12-08 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Extension de durée de vie réplicative dans des maladies de vieillissement prématuré à l'aide d'isoformes p53
|
EP3317295B1
(fr)
|
2015-07-04 |
2022-05-18 |
Evaxion Biotech A/S |
Protéines et acides nucléiques utiles dans des vaccins ciblant pseudomonas aeruginosa
|
DK3328423T3
(da)
*
|
2015-07-31 |
2021-07-26 |
Bayer Animal Health Gmbh |
Forbedret immunrespons hos fisk
|
WO2017040380A2
(fr)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Variants de fc d'anticorps modifiés
|
AU2016338680B2
(en)
|
2015-10-16 |
2022-11-17 |
Fate Therapeutics, Inc. |
Platform for the induction and maintenance of ground state pluripotency
|
WO2017070337A1
(fr)
|
2015-10-20 |
2017-04-27 |
Cellular Dynamics International, Inc. |
Procédés de différenciation dirigée de cellules souches pluripotentes en cellules immunes
|
JP6983771B2
(ja)
|
2015-10-30 |
2021-12-17 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
幹細胞からt細胞を作製する方法および該t細胞を用いた免疫療法的方法
|
WO2017079202A1
(fr)
|
2015-11-02 |
2017-05-11 |
Board Of Regents, The University Of Texas System |
Méthodes d'activation de cd40 et blocage de points de contrôle immunitaires
|
US20190038713A1
(en)
|
2015-11-07 |
2019-02-07 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
CA3004438A1
(fr)
|
2015-11-09 |
2017-05-18 |
The Children's Hospital Of Philadelphia |
Glypicane 2 a utiliser en tant que marqueur cancereux et cible therapeutique
|
US11064680B2
(en)
*
|
2015-11-13 |
2021-07-20 |
Applied Lifesciences And Systems Llc |
Automatic system and method for injecting a substance into an animal
|
CA3011920A1
(fr)
*
|
2016-02-02 |
2017-08-10 |
Benchmark Animal Health Limited |
Methodes de production de virus
|
WO2017144523A1
(fr)
|
2016-02-22 |
2017-08-31 |
Evaxion Biotech Aps |
Protéines et acides nucléiques utiles dans des vaccins ciblant staphylococcus aureus
|
US20190177391A1
(en)
|
2016-03-31 |
2019-06-13 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(fr)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination ciblant ichthyophthirius multifiliis
|
WO2017220787A1
(fr)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccin contre l'infection provoquée par aeromonas salmonicida
|
US20180030478A1
(en)
|
2016-07-01 |
2018-02-01 |
Research Development Foundation |
Elimination of proliferating cells from stem cell-derived grafts
|
WO2018015575A1
(fr)
|
2016-07-22 |
2018-01-25 |
Evaxion Biotech Aps |
Protéines chimériques pour induire une immunité vis-à-vis d'une infection à s. aureus
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
AU2017319702A1
(en)
|
2016-09-02 |
2019-04-11 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
JP7212615B2
(ja)
|
2016-10-05 |
2023-01-25 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
|
CN110050061A
(zh)
|
2016-10-05 |
2019-07-23 |
富士胶片细胞动力公司 |
从具有MeCP2破坏的诱导多能干细胞生成成熟谱系
|
EP3551226A1
(fr)
|
2016-12-12 |
2019-10-16 |
MultiVir Inc. |
Méthodes et compositions comprenant une thérapie génique virale et un inhibiteur de point de contrôle immunitaire pour le traitement et la prévention du cancer et des maladies infectieuses
|
WO2018127545A1
(fr)
|
2017-01-05 |
2018-07-12 |
Evaxion Biotech Aps |
Vaccins ciblant pseudomonas aeruginosa
|
JP7181219B2
(ja)
|
2017-04-18 |
2022-11-30 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
抗原特異的免疫エフェクター細胞
|
CN107099496B
(zh)
*
|
2017-04-25 |
2021-04-13 |
中国农业科学院哈尔滨兽医研究所 |
融合表达鸡传染性法氏囊病毒vp2蛋白和沙门菌属外膜蛋白的重组乳酸菌菌株及其用途
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
EP3704250A1
(fr)
|
2017-11-03 |
2020-09-09 |
InteRNA Technologies B.V. |
Molécule de micro-arn, équivalent, antagomir, ou source de cette molécule pour le traitement et/ou le diagnostic d'une affection et/ou d'une maladie associée à une déficience neuronale ou pour la (ré)génération neuronale
|
WO2019099493A1
(fr)
|
2017-11-14 |
2019-05-23 |
Henry Ford Health System |
Compositions destinées à être utilisées dans le traitement et la prévention de troubles cardiovasculaires résultant d'une lésion cérébrovasculaire
|
CA3083873A1
(fr)
|
2017-12-06 |
2019-06-13 |
Intervet International B.V. |
Utilisation d'une proteine non structurale issue de prv pour proteger contre l'inflammation du cur et du muscle squelettique
|
RU2020124404A
(ru)
|
2018-01-05 |
2022-01-24 |
Оттава Хоспитл Рисерч Инститьют |
Векторы на основе модифицированного вируса осповакцины
|
WO2019145399A1
(fr)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccins pour la prophylaxie d'infections par s. aureus
|
WO2020036635A2
(fr)
|
2018-03-19 |
2020-02-20 |
Multivir Inc. |
Procédés et compositions comprenant une thérapie génique suppressive de tumeur et des agonistes de cd122/cd132 pour le traitement du cancer
|
SG11202009697RA
(en)
|
2018-03-30 |
2020-10-29 |
Univ Geneve |
Micro rna expression constructs and uses thereof
|
RU2702716C2
(ru)
*
|
2018-04-03 |
2019-10-09 |
Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) |
Рекомбинантная плазмида pHis6-flagG-protE, обеспечивающая синтез рекомбинантного химерного белка, включающего эпитопы гликопротеина Е вируса клещевого энцефалита и флагеллин G S.typhii и используемого в качестве основы для вакцины против вируса клещевого энцефалита
|
SG11202102058UA
(en)
|
2018-08-30 |
2021-03-30 |
Tenaya Therapeutics Inc |
Cardiac cell reprogramming with myocardin and ascl1
|
US20220000932A1
(en)
|
2018-09-28 |
2022-01-06 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
WO2020083904A1
(fr)
|
2018-10-22 |
2020-04-30 |
Evaxion Biotech Aps |
Vaccins ciblant m. catharrhalis
|
WO2020171889A1
(fr)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocage de l'accumulation des lipides ou de l'inflammation dans la maladie oculaire thyroïdienne
|
EP3931206A1
(fr)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Vaccins ciblant h. influenzae
|
US20230137971A1
(en)
|
2019-07-11 |
2023-05-04 |
Tenaya Therapeutics Inc. |
Cardiac cell reprogramming with micrornas and other factors
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
US20210147525A1
(en)
|
2019-10-18 |
2021-05-20 |
The Regents Of The University Of California |
Methods and compositions for treating pathogenic blood vessel disorders
|
WO2021113644A1
(fr)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinaisons comprenant un activateur de lymphocytes t cd8+, un inhibiteur de point de contrôle immunitaire et une radiothérapie en vue d'obtenir des effets ciblés et abscopal pour le traitement du cancer
|
EP4087593A1
(fr)
|
2020-01-06 |
2022-11-16 |
Evaxion Biotech A/S |
Vaccins ciblant neisseria gonorrhoeae
|
JP2023515672A
(ja)
|
2020-03-02 |
2023-04-13 |
テナヤ セラピューティクス, インコーポレイテッド |
心筋細胞発現マイクロrnaによる遺伝子ベクター制御
|
JP2023520359A
(ja)
|
2020-03-25 |
2023-05-17 |
エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム |
放射性核種イメージングのためのレポーター系
|
WO2021240240A1
(fr)
|
2020-05-27 |
2021-12-02 |
Antion Biosciences Sa |
Molécules d'adaptateurs pour rediriger des lymphocytes t à car vers un antigène d'intérêt
|
KR20230019453A
(ko)
|
2020-05-29 |
2023-02-08 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법
|
CN116323677A
(zh)
|
2020-05-29 |
2023-06-23 |
富士胶片细胞动力公司 |
视网膜色素上皮和光感受器双层及其用途
|
WO2022053130A1
(fr)
|
2020-09-09 |
2022-03-17 |
Sid Alex Group, S.R.O. |
Antago-mir-155 pour le traitement des cancers induits par v-src, c-src-tyrosine kinase
|
JP2024508088A
(ja)
|
2021-02-09 |
2024-02-22 |
ユニバーシティ オブ ヒューストン システム |
全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス
|
WO2022175815A1
(fr)
|
2021-02-19 |
2022-08-25 |
Pfizer Inc. |
Procédés de protection de l'arn
|
CN117242173A
(zh)
|
2021-05-03 |
2023-12-15 |
安斯泰来再生医药协会 |
产生成熟角膜内皮细胞的方法
|
AU2022270117A1
(en)
|
2021-05-07 |
2023-11-02 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature hepatocytes
|
US20220389436A1
(en)
|
2021-05-26 |
2022-12-08 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
EP4366762A1
(fr)
|
2021-07-05 |
2024-05-15 |
Evaxion Biotech A/S |
Vaccins ciblant neisseria gonorrhoeae
|
WO2023089556A1
(fr)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Réduction du risque de mimétisme antigènique dans des médicaments immunogènes
|
WO2023144779A1
(fr)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Variants d'antigène de coronavirus
|
WO2023178191A1
(fr)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Système d'administration de gène hsv persistant
|
GB202205265D0
(en)
|
2022-04-11 |
2022-05-25 |
Mogrify Ltd |
Cell conversion
|
WO2023213393A1
(fr)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Variants de protéine staphylococcique et parties tronquées
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023239940A1
(fr)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Variants de fc igg1 sélectifs de fcriib modifiés et leurs utilisations
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|